ATE311364T1 - Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid - Google Patents
Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamidInfo
- Publication number
- ATE311364T1 ATE311364T1 AT00926805T AT00926805T ATE311364T1 AT E311364 T1 ATE311364 T1 AT E311364T1 AT 00926805 T AT00926805 T AT 00926805T AT 00926805 T AT00926805 T AT 00926805T AT E311364 T1 ATE311364 T1 AT E311364T1
- Authority
- AT
- Austria
- Prior art keywords
- methoxy
- bnzamid
- methylaminothiocarbonylaminosulfonylphenyl
- ethy
- chlorine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19917233A DE19917233A1 (de) | 1999-04-16 | 1999-04-16 | Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids |
PCT/EP2000/002984 WO2000063167A1 (en) | 1999-04-16 | 2000-04-04 | Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE311364T1 true ATE311364T1 (de) | 2005-12-15 |
Family
ID=7904803
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00926805T ATE311364T1 (de) | 1999-04-16 | 2000-04-04 | Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid |
AT05024254T ATE414059T1 (de) | 1999-04-16 | 2000-04-04 | Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05024254T ATE414059T1 (de) | 1999-04-16 | 2000-04-04 | Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid |
Country Status (33)
Country | Link |
---|---|
US (1) | US6723751B1 (de) |
EP (2) | EP1637519B1 (de) |
JP (1) | JP4662640B2 (de) |
KR (1) | KR100700302B1 (de) |
CN (1) | CN1168712C (de) |
AR (1) | AR023479A1 (de) |
AT (2) | ATE311364T1 (de) |
AU (1) | AU773246B2 (de) |
BR (1) | BR0010658A (de) |
CA (1) | CA2370388C (de) |
CZ (1) | CZ302459B6 (de) |
DE (3) | DE19917233A1 (de) |
DK (1) | DK1173418T3 (de) |
EE (1) | EE04612B1 (de) |
ES (1) | ES2251996T3 (de) |
HK (1) | HK1046270B (de) |
HR (1) | HRP20010744B1 (de) |
HU (1) | HU229082B1 (de) |
IL (2) | IL145921A0 (de) |
ME (1) | MEP55708A (de) |
MX (1) | MXPA01010275A (de) |
MY (1) | MY122588A (de) |
NO (1) | NO327798B1 (de) |
NZ (1) | NZ514788A (de) |
PL (1) | PL203809B1 (de) |
RS (1) | RS50916B (de) |
RU (1) | RU2235089C2 (de) |
SI (1) | SI1173418T1 (de) |
SK (1) | SK287175B6 (de) |
TR (2) | TR200501142T2 (de) |
TW (1) | TWI276622B (de) |
WO (1) | WO2000063167A1 (de) |
ZA (1) | ZA200108400B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080008440A (ko) * | 2003-03-17 | 2008-01-23 | 니뽄 다바코 산교 가부시키가이샤 | Cetp 억제제의 약제학적 조성물 |
TWI494102B (zh) * | 2003-05-02 | 2015-08-01 | Japan Tobacco Inc | 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0612724T3 (da) * | 1993-02-23 | 1997-06-16 | Hoechst Ag | Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika |
DE19505397A1 (de) * | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
CN1195524C (zh) * | 1998-09-10 | 2005-04-06 | 阿文蒂斯药物德国有限公司 | 苯磺酰(硫)脲与β-受体阻滞剂联合在制备用于心脏迷走神经机能障碍治疗和预防的药物中的用途 |
-
1999
- 1999-04-16 DE DE19917233A patent/DE19917233A1/de not_active Withdrawn
-
2000
- 2000-04-04 DK DK00926805T patent/DK1173418T3/da active
- 2000-04-04 RS YUP-720/01A patent/RS50916B/sr unknown
- 2000-04-04 NZ NZ514788A patent/NZ514788A/xx not_active IP Right Cessation
- 2000-04-04 EP EP05024254A patent/EP1637519B1/de not_active Expired - Lifetime
- 2000-04-04 MX MXPA01010275A patent/MXPA01010275A/es active IP Right Grant
- 2000-04-04 IL IL14592100A patent/IL145921A0/xx active IP Right Grant
- 2000-04-04 DE DE60040811T patent/DE60040811D1/de not_active Expired - Lifetime
- 2000-04-04 BR BR0010658-5A patent/BR0010658A/pt not_active IP Right Cessation
- 2000-04-04 AT AT00926805T patent/ATE311364T1/de active
- 2000-04-04 CA CA002370388A patent/CA2370388C/en not_active Expired - Fee Related
- 2000-04-04 JP JP2000612263A patent/JP4662640B2/ja not_active Expired - Fee Related
- 2000-04-04 PL PL351245A patent/PL203809B1/pl unknown
- 2000-04-04 AU AU45428/00A patent/AU773246B2/en not_active Ceased
- 2000-04-04 WO PCT/EP2000/002984 patent/WO2000063167A1/en active IP Right Grant
- 2000-04-04 TR TR2005/01142T patent/TR200501142T2/xx unknown
- 2000-04-04 TR TR2001/02993T patent/TR200102993T2/xx unknown
- 2000-04-04 ME MEP-557/08A patent/MEP55708A/xx unknown
- 2000-04-04 ES ES00926805T patent/ES2251996T3/es not_active Expired - Lifetime
- 2000-04-04 AT AT05024254T patent/ATE414059T1/de not_active IP Right Cessation
- 2000-04-04 SK SK1458-2001A patent/SK287175B6/sk not_active IP Right Cessation
- 2000-04-04 SI SI200030775T patent/SI1173418T1/sl unknown
- 2000-04-04 EE EEP200100532A patent/EE04612B1/xx not_active IP Right Cessation
- 2000-04-04 DE DE60024431T patent/DE60024431T2/de not_active Expired - Lifetime
- 2000-04-04 KR KR1020017013220A patent/KR100700302B1/ko not_active IP Right Cessation
- 2000-04-04 CZ CZ20013672A patent/CZ302459B6/cs not_active IP Right Cessation
- 2000-04-04 HU HU0200791A patent/HU229082B1/hu not_active IP Right Cessation
- 2000-04-04 EP EP00926805A patent/EP1173418B1/de not_active Expired - Lifetime
- 2000-04-04 CN CNB008063184A patent/CN1168712C/zh not_active Expired - Fee Related
- 2000-04-04 RU RU2001130886/04A patent/RU2235089C2/ru not_active IP Right Cessation
- 2000-04-13 AR ARP000101712A patent/AR023479A1/es not_active Application Discontinuation
- 2000-04-14 US US09/549,538 patent/US6723751B1/en not_active Expired - Lifetime
- 2000-04-14 MY MYPI20001609A patent/MY122588A/en unknown
- 2000-05-10 TW TW089106840A patent/TWI276622B/zh not_active IP Right Cessation
-
2001
- 2001-10-12 ZA ZA200108400A patent/ZA200108400B/xx unknown
- 2001-10-14 IL IL145921A patent/IL145921A/en not_active IP Right Cessation
- 2001-10-15 NO NO20015014A patent/NO327798B1/no not_active IP Right Cessation
- 2001-10-15 HR HR20010744A patent/HRP20010744B1/xx not_active IP Right Cessation
-
2002
- 2002-10-30 HK HK02107874.4A patent/HK1046270B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69811892D1 (de) | Kristalline form von omeprazol-natriumsalz | |
DE60004317D1 (de) | Salze von Sulfonium-Verbindungen | |
ATE236899T1 (de) | Neue kristallinische form des kaliumsalzes des (s)-omeprazols | |
EE200000031A (et) | Uued spiroasabitsüklilised heterotsüklilised ühendid | |
EE200300001A (et) | Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm | |
NO20016319D0 (no) | VLA-4 inhibitor-forbindelser | |
ATE257836T1 (de) | Salz von naphthyridincarbonsäure-derivaten | |
ATE231521T1 (de) | Kristalline formen von eto2c-ch2-(r)cgl-aze-pab- oh | |
HUP0202536A3 (en) | Crystals of the sodium salt of pravastatin | |
NO20020030L (no) | Krystallinske 1-metylkarbapenemforbindelser | |
ID28483A (id) | 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida | |
ID23803A (id) | Turunan-turunan 2-(4-aril atau heteroaril-piperazin-1-ilmetil)-1h-indola | |
DE60107074D1 (de) | Kristallin form ii von cabergolin | |
NO20021525L (no) | Polymorft salt | |
ATE339438T1 (de) | Substanziell kristalline form von melagatran | |
ID27766A (id) | Garam-garam paroksetin | |
EE200100381A (et) | Morfolinobensamiidi uued soolad | |
EE200100017A (et) | N-tert-butüülhüdroksüülamiini uued soolad | |
ATE311364T1 (de) | Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid | |
DE69940563D1 (de) | Wachstum von aluminium-einkristallen | |
DK1224179T3 (da) | Natrium-hydrogen-udbytter type 1-inhibitorkrystaller | |
ATE243218T1 (de) | 2''-deoxyhygromycinderivate | |
ID26940A (id) | Garam fosfat isopropil-metil-[2-(3-n-propoksifenoksi)-etil] amina | |
ID25793A (id) | Garam-garam paroksetin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1173418 Country of ref document: EP |